Uriel Ortega‐Rodriguez

449 total citations
12 papers, 126 citations indexed

About

Uriel Ortega‐Rodriguez is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases. According to data from OpenAlex, Uriel Ortega‐Rodriguez has authored 12 papers receiving a total of 126 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Infectious Diseases. Recurrent topics in Uriel Ortega‐Rodriguez's work include Monoclonal and Polyclonal Antibodies Research (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Glycosylation and Glycoproteins Research (3 papers). Uriel Ortega‐Rodriguez is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Glycosylation and Glycoproteins Research (3 papers). Uriel Ortega‐Rodriguez collaborates with scholars based in United States, Thailand and Venezuela. Uriel Ortega‐Rodriguez's co-authors include Hang Xie, Neeraj Kapoor, Je‐Nie Phue, Peter Radvák, Hyung‐Joon Kwon, Martina Košíková, Jeff Fairman, Rong‐Fong Shen, Miao Xu and Dominic Esposito and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Uriel Ortega‐Rodriguez

12 papers receiving 125 citations

Peers

Uriel Ortega‐Rodriguez
Thandeka Moyo-Gwete South Africa
Kathy Stephens United States
Lauren Walker United States
Mansi Purwar United States
Yuxia Bo Canada
Marcel Stern Germany
Art Marzok Canada
Thandeka Moyo-Gwete South Africa
Uriel Ortega‐Rodriguez
Citations per year, relative to Uriel Ortega‐Rodriguez Uriel Ortega‐Rodriguez (= 1×) peers Thandeka Moyo-Gwete

Countries citing papers authored by Uriel Ortega‐Rodriguez

Since Specialization
Citations

This map shows the geographic impact of Uriel Ortega‐Rodriguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uriel Ortega‐Rodriguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uriel Ortega‐Rodriguez more than expected).

Fields of papers citing papers by Uriel Ortega‐Rodriguez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uriel Ortega‐Rodriguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uriel Ortega‐Rodriguez. The network helps show where Uriel Ortega‐Rodriguez may publish in the future.

Co-authorship network of co-authors of Uriel Ortega‐Rodriguez

This figure shows the co-authorship network connecting the top 25 collaborators of Uriel Ortega‐Rodriguez. A scholar is included among the top collaborators of Uriel Ortega‐Rodriguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uriel Ortega‐Rodriguez. Uriel Ortega‐Rodriguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Ortega‐Rodriguez, Uriel, Chikkathur N. Madhavarao, Tongzhong Ju, et al.. (2025). Effect of different cell culture media on the production and glycosylation of a monoclonal antibody from a CHO cell line. Cytotechnology. 77(3). 81–81. 1 indexed citations
2.
Ortega‐Rodriguez, Uriel, Yasuyuki Matsumoto, Wells W. Wu, et al.. (2025). Dual functional POGases from bacteria encompassing broader O-glycanase and adhesin activities. Nature Communications. 16(1). 1960–1960. 2 indexed citations
3.
Baldisseri, Donna M., Shen Luo, Uriel Ortega‐Rodriguez, et al.. (2025). NMR-based structural integrity analysis of therapeutic monoclonal antibodies: a comparative study of Humira and its biosimilars. mAbs. 17(1). 2551208–2551208. 2 indexed citations
4.
Ortega‐Rodriguez, Uriel, et al.. (2025). Reduced IgG1 Antibody Left-Twisted Antiparallel β-Sheet Structure Stability Occurs under Metal-Catalyzed Oxidation Conditions in the Presence of Polysorbates. Molecular Pharmaceutics. 22(5). 2623–2638. 2 indexed citations
5.
Biel, Thomas, Uriel Ortega‐Rodriguez, Edward C. Meek, et al.. (2024). Model acetylcholinesterase‐Fc fusion glycoprotein biotechnology system for the manufacture of an organophosphorus toxicant bioscavenging countermeasure. Bioengineering & Translational Medicine. 9(5). e10666–e10666. 1 indexed citations
6.
Ortega‐Rodriguez, Uriel, Guozhang Zou, Thomas Biel, et al.. (2024). A chemoenzymatic method for simultaneous profiling N- and O-glycans on glycoproteins using one-pot format. Cell Reports Methods. 4(8). 100834–100834. 2 indexed citations
7.
Hong, Jessica, Hyung Joon Kwon, Raúl E. Cachau, et al.. (2022). Dromedary camel nanobodies broadly neutralize SARS-CoV-2 variants. Proceedings of the National Academy of Sciences. 119(18). 27 indexed citations
8.
Viana, Sayonara M., Alba L. Montoya, Augusto M. Carvalho, et al.. (2022). Serodiagnosis and therapeutic monitoring of New-World tegumentary leishmaniasis using synthetic type-2 glycoinositolphospholipid-based neoglycoproteins. Emerging Microbes & Infections. 11(1). 2147–2159. 4 indexed citations
9.
Biel, Thomas, Uriel Ortega‐Rodriguez, Hang Xie, et al.. (2022). SARS-CoV-2 spike protein variant binding affinity to an angiotensin-converting enzyme 2 fusion glycoproteins. PLoS ONE. 17(12). e0278294–e0278294. 5 indexed citations
10.
Biel, Thomas, Guozhang Zou, Uriel Ortega‐Rodriguez, et al.. (2022). An etanercept O-glycovariant with enhanced potency. Molecular Therapy — Methods & Clinical Development. 25. 124–135. 9 indexed citations
11.
Radvák, Peter, Hyung‐Joon Kwon, Martina Košíková, et al.. (2021). SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains. Nature Communications. 12(1). 6559–6559. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026